HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Conjunctival Tumor

Conjunctival Tumor

In the realm of cancer research, conjunctival tumors stand out as a distinctive area of focus. These growths, while uncommon, present significant challenges due to their location on the delicate membrane of the eye. Understanding their complex nature involves delving into various factors, such as environmental influences like UV exposure and underlying genetic susceptibilities. Cutting-edge imaging technologies play a pivotal role in early detection, critical for improved treatment outcomes. Evolving treatment approaches, including precise surgical techniques and innovative therapies like immunotherapy, underscore the dynamic landscape of conjunctival tumor management. By amalgamating insights from diverse fields, researchers strive to refine both preventive measures and therapeutic strategies, aiming for more effective control and, ultimately, better outcomes for patients grappling with this condition.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp